◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Towa Pharmaceutical Co., Ltd. (4553) Financial History

Name: Towa Pharmaceutical Co., Ltd. (4553) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Towa Pharmaceutical Co., Ltd. (4553) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kadoma, Japan with about 4,923 employees. Its market capitalization is roughly JPY 182 billion. In the fiscal year ended 2026-03-31, 4553 reported JPY 273.7B in revenue and JPY 5.2B in net income.

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas.

Interactive charts & full statements →

4553 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 273.7B	JPY 259.6B	JPY 227.9B	JPY 208.9B
Gross Profit	JPY 99.1B	JPY 94.7B	JPY 81.4B	JPY 72.7B
Operating Income (EBIT)	JPY 23.1B	JPY 23.2B	JPY 17.6B	JPY 5.5B
Net Income	JPY 5.2B	JPY 19.0B	JPY 16.2B	JPY 2.2B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4553 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 3.9B)	(JPY 3.0B)	(JPY 3.0B)	(JPY 3.1B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4553 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 475.3B	JPY 470.8B	JPY 430.7B	JPY 371.3B	—
Total Liabilities	JPY 297.2B	JPY 299.2B	JPY 274.8B	JPY 234.5B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4553 viewer.

4553 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4540 · Tsumura & Co. — $280 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion
4887 · Sawai Group Holdings Co., Ltd. — $184 billion
4547 · Kissei Pharmaceutical Co., Ltd. — $171 billion
4521 · Kaken Pharmaceutical Co., Ltd. — $151 billion
TEVA · Teva Pharmaceutical Industries Limited — ₪125 billion
4534 · Mochida Pharmaceutical Co., Ltd. — $114 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4552 All “0-9” companies 4554 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.